Genta, Inc. (GNTA) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genta, Inc. (GNTA)

GNTA 2.300

+0.4%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Nobrega who started this subject	7/14/2003 3:04:12 PM
From: bob zagorin	Read Replies (2) of 1870

as you know, i'm out as of a couple weeks ago but still follow closely. saw this headline but don't have access to full story. propbably exoplains today's drop.. RealCommentary from TheStreet.com Investor Hands Out a Giant Slice of Genta Monday July 14, 8:18 am ET By Adam Feuerstein, Senior Writer Lindsay Rosenwald and the investment funds he controls under the Paramount Capital Asset Management umbrella own about 40% of the biotech firm Genta (NasdaqNM:GNTA - News). But now, Paramount has parsed out 5.5 million Genta shares to some of its investors, who will be free to sell the stock at any time. What this means for Genta's near-term stock price is anyone's guess because it's impossible to know whether these investors will sell the stock now to lock in profits, or hold on to it and wait for the Big Event -- the anticipated release, sometime this summer, of data from three pivotal Phase III studies of Genta's antisense cancer drug Genasense..."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next